Glenmark gets marketing approval for Ryaltris in 13 EU, UK countries

Sales of the nasal spray continue to progress well in Australia, South Africa, Ukraine and Uzbekistan, it said adding the company has also initiated the commercial launch in Russia in Q1, FY21-22.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3AUI7sx
via IFTTT

0 comments:

Post a Comment